Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Kallioniemi, O. Kallioniemi, J. Piper, M. Tanner, T. Stokke, Ling Chen, H. Smith, D. Pinkel, J. Gray, F. Waldman (1994)
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.Proceedings of the National Academy of Sciences of the United States of America, 91 6
P. Cairns, Margaret Shaw, M. Knowles (1993)
Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.Cancer research, 53 6
J. Piper, J. Piper, D. Rutovitz, D. Sudar, D. Sudar, A. Kallioniemi, A. Kallioniemi, O. Kallioniemi, F. Waldman, J. Gray, J. Gray, D. Pinkel, D. Pinkel (1995)
Computer image analysis of comparative genomic hybridization.Cytometry, 19 1
(1992)
Comparative genomic hybridiza-MOLECULAR
K. Matsumura, A. Kallioniemi, O. Kallioniemi, L. Chen, H. Smith, D. Pinkel, J. Gray, F. Waldman (1992)
Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.Cancer research, 52 12
G. Sauter, H. Moch, P. Carroll, R. Kerschmann, M. Mihatsch, F. Waldman (1995)
Chromosome‐9 loss detected by fluorescence in situ hybridization in bladder cancerInternational Journal of Cancer, 64
O. Kallioniemi, A. Kallioniemi, J. Piper, J. Isola, F. Waldman, J. Gray, D. Pinkel (1994)
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, 10
T. Sano, T. Tsujino, Kazuhiro Yoshida, H. Nakayama, K. Haruma, Hisao Ito, Y. Nakamura, G. Kajiyama, E. Tahara (1991)
Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.Cancer research, 51 11
G. Dalbagni, J. Presti, W. Fair, V. Reuter, C. Cordon-Cardo (1993)
Genetic alterations in bladder cancerThe Lancet, 342
G. Sauter, H. Moch, D. Moore, Peter Carroll, R. Kerschmann, K. Chew, M. Mihatsch, F. Gudat, F. Waldman (1993)
Heterogeneity of erbB-2 gene amplification in bladder cancer.Cancer research, 53 10 Suppl
Z. Gibas, Prout Gr, Connolly Jg, Pontes Je, A. Sandberg (1984)
Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.Cancer research, 44 3
(1992)
Comparative genomic hybridization for molecular 6;enetic analysis of solid tumors
G. Sauter, G. Deng, Holger, Moch, R. Kerschmann, K. Matsumura, S. Vries, Tracy George, José Fuentes, Peter Carroll, J. Michael, Mihatsch, F. Waldman (1994)
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.The American journal of pathology, 144 4
Takaaki Sato, H. Saito, R. Morita, S. Koi, Je Lee, Y. Nakamura (1991)
Allelotype of human ovarian cancer.Cancer research, 51 19
(1992)
Molecular hiology
P. Devilee, M. vanVliet, P. Vansloun, N. KuipersDijkshoorn, J. Hermans, P. Pearson, C. Cornelisse (1991)
Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.Oncogene, 6 9
M. Knowles, Patricia Elder, M. Williamson, Cairns Jp, Margaret Shaw, M. Law (1994)
Allelotype of human bladder cancer.Cancer research, 54 2
V. Babu, M. Lutz, B. Miles, R. Farah, L. Weiss, D. Dyke (1987)
Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.Cancer research, 47 24 Pt 1
O. Kallioniemi, A. Kallioniemi, D. Sudar, D. Rutovitz, J. Gray, F. Waldman, D. Pinkel (1993)
Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors.Seminars in cancer biology, 4 1
Borland Rn, C. Brendler, W. Isaacs (1992)
Molecular biology of bladder cancer.Hematology/oncology clinics of North America, 6 1
R. Vanni, R. Scarpa, M. Nieddu, E. Usai (1988)
Cytogenetic investigation on 30 bladder carcinomas.Cancer genetics and cytogenetics, 30 1
(1993)
parative genomic hybridization and loss of heterozygosity studies in ovarian cancer
R. Morita, Jiro Ishikawa, Masayoshi Tsutsumi, Kazumasa Hikiji, Yutaka Tsukada, Sadao Kamidono, Sakan Maeda, Yusuke Nakamura (1991)
Allelotype of renal cell carcinoma.Cancer research, 51 3
E. Neville, M. Stewart, A. Swift, T. Liloglou, H. Ross, J. Gosney, R. Donnelly, J. Field (1996)
Allelotype of non-small cell lung cancer.International journal of oncology, 9 3
William Foulkes, Ian Campbell, Gordon Stamp, John Trowsdale (1993)
Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.British Journal of Cancer, 67
C. Berger, A. Sandberg, I. Todd, R. Pennington, F. Haddad, B. Hecht, F. Hecht (1986)
Chromosomes in kidney, ureter, and bladder cancer.Cancer genetics and cytogenetics, 23 1
W. Smeets, R. Pauwels, L. Laarakkers, F. Debruyne, J. Geraedts (1987)
Chromosomal analysis of bladder cancer. III. Nonrandom alterations.Cancer genetics and cytogenetics, 29 1
M. Knowles, Shaw Me, Proctor Aj (1993)
Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.Oncogene, 8 5
E. Tsuchiya, Yusuke Nakamura, Siu‐Yuhe Weng, Ken Nakagawa, S. Tsuchiya, Haruo Sugano, Tomoyuki Kitagawa (1992)
Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.Cancer research, 52 9
David Wood, William Fair, R.S.K. Chaganti (1992)
Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.The Journal of urology, 147 1
T. Habuchi, O. Ogawa, Y. Kakehi, K. Ogura, M. Koshiba, S. Hamazaki, R. Takahashi, T. Sugiyama, O. Yoshida (1993)
Accumulated allelic losses in the development of invasive urothelial cancerInternational Journal of Cancer, 53
Comparative genomic hybridization (CGH) makes it possible to detect losses and gains of DNA sequences along all chromosomes in a tumor specimen based on the hybridization of differentially labeled tumor and normal DNA to normal human metaphase chromosomes. In this study, CGH analysis was applied to the identification of genomic imbalances in 26 bladder cancers in order to gain information on the genetic events underlying the development and progression of this malignancy. Losses affecting 11p, 11q, 8p, 9, 17p, 3p, and 12q were all seen in more than 20% of the tumors. The minimal common region of loss in each chromosome was identified based on the analysis of overlapping deletions in different tumors. Gains of DNA sequences were most often found at chromosomal regions distinct from the locations of currently known oncogenes. The bands involved in more than 10% of the tumors were 8q21, 13q21‐q34, 1q31, 3q24‐q26, and 1p22. In conclusion, these CGH data highlight several previously unreported genetic alterations in bladder cancer. Further detailed studies of these regions with specific molecular genetic techniques may lead to the identification of tumor suppressor genes and oncogenes that play an important role in bladder tumorigenesis.
Genes, Chromosomes and Cancer – Wiley
Published: Mar 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.